| Mrs Dianne Morris Jones, LMHC | |
|
5415 Nw 88th St Ste 100, Johnston, IA 50131-2951 | |
| (515) 727-1338 | |
| (515) 727-1340 |
| Full Name | Mrs Dianne Morris Jones |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 5415 Nw 88th St Ste 100, Johnston, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306137310 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 001312 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dianne Morris Jones, LMHC 5415 Nw 88th St Ste 100, Johnston, IA 50131-2951 Ph: (515) 727-1338 | Mrs Dianne Morris Jones, LMHC 5415 Nw 88th St Ste 100, Johnston, IA 50131-2951 Ph: (515) 727-1338 |
News Archive
According to the United States Centers for Disease Control and Prevention, breast cancer is the most common cancer in women. For patients whose breast cancers are hormone-dependent, current treatment focuses on using drugs that block estrogen (a type of hormone) from attaching to estrogen receptors on tumor cells to prevent the cells from growing and spreading.
PuriCore, the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, was named as winner of the Emerging Life Sciences Company of the Year award, at the Eastern Technology Council's 17th annual Enterprise Awards gala.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced today that it has completed the sale of certain assets related to its hemofiltration product line to Baxter International Inc. (NYSE: BAX), consistent with the previously announced terms of the agreement.
"Recent media reports highlighting NHS statistics which show a rapid increase in the number of boys and young men being admitted to hospital suffering from eating disorders are welcome, if only for helping to draw attention to this issue.
› Verified 3 days ago
Ashley Beenken, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5415 Nw 88th St Ste 100, Johnston, IA 50131 Phone: 515-727-1338 | |
Mr. Jason Van Zee, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5415 Nw 88th St Ste 100, Johnston, IA 50131 Phone: 515-727-1338 | |
Katherine Paige Simmons, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5619 Nw 86th St Ste 500, Johnston, IA 50131 Phone: 515-981-2848 | |
Mrs. Mary Teresa Lothe, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5415 Nw 88th St Ste 100, Johnston, IA 50131 Phone: 515-727-1338 | |
Kristy Brown, LMHC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6165 Nw 86th St, Johnston, IA 50131 Phone: 515-259-0565 | |
Edina Zenkovic, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |